4//SEC Filing
SMITH J. JEFFERSON 4
Accession 0000950170-24-072049
CIK 0001357874other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:12 PM ET
Size
10.2 KB
Accession
0000950170-24-072049
Insider Transaction Report
Form 4
SMITH J. JEFFERSON
Chief Research Officer
Transactions
- Exercise/Conversion
Common Stock
2024-06-07+163→ 68,609 total - Exercise/Conversion
Restricted Stock Units
2024-06-07−163→ 0 total→ Common Stock (163 underlying) - Sale
Common Stock
2024-06-10$11.79/sh−50$590→ 68,559 total
Holdings
- 7,931(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Represents the vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2024.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.70 to $12.00. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
- [F5]On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on June 7, 2024.
Documents
Issuer
PRECISION BIOSCIENCES INC
CIK 0001357874
Entity typeother
Related Parties
1- filerCIK 0001770169
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 5:12 PM ET
- Size
- 10.2 KB